Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region

Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region Publisher Pubmed

Ahmed SO¹ ; Fakih RE¹ ; Elhaddad A² ; Hamidieh AA³ ; Altbakhi A⁴ ; Chaudhry QUN⁵ ; Bazarbachi A⁶ ; Adil S⁷ ; Alkhabori M⁸ ; Othman TB⁹ ; Gaziev J¹⁰ ; Khalaf M¹¹ ; Alshammeri S¹² ; Alotaibi S¹³ Show All Authors

Ahmed SO¹
Fakih RE¹
Elhaddad A²
Hamidieh AA³
Altbakhi A⁴
Chaudhry QUN⁵
Bazarbachi A⁶
Adil S⁷
Alkhabori M⁸
Othman TB⁹
Gaziev J¹⁰
Khalaf M¹¹
Alshammeri S¹²
Alotaibi S¹³
Alshahrani M¹³
Bekadja MA¹⁴
Ibrahim A¹⁵
Alwahadneh AM¹⁶
Altarshi M¹⁷
Alsaeed A¹⁸
Madani A¹⁹
Abboud M⁶
Abujazar H⁴
Bakr M¹⁰
Abosoudah I²⁰
Cheikh JE⁶
Almasari A²⁰
Alfraih F¹
Baldomero H²¹
Elsolh H¹
Niederwieser D^{22, 23}
Chaudhri N¹
Aljurf M¹

Show Affiliations

1. King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2. National Cancer Institute, Cairo University, Cairo, Egypt
3. Tehran University of Medical Sciences, Hematology, Oncology & SCT Research Ctr., Tehran, Iran
4. King Hussein Cancer Center, Amman, Jordan
5. Armed Forces Bone Marrow Transplant Centre, National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan
6. Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon
7. Department of Oncology, the Aga Khan University, Karachi, Pakistan
8. Sultan Qaboos University, Muscat, Oman
9. Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia
10. National Center for Cancer Care & Research Hamad Medical Corporation, Doha, Qatar
11. Maadi Armed Forces Medical Compound Hematology, Oncology Hospital, Cairo, Egypt
12. Faculty of Medicine, Kuwait University, Jabriya, Kuwait
13. m Prince Sultan Military Medical City, Riyadh, Saudi Arabia
14. University Hospital Establishment 1st Nov, Oran, Algeria
15. Makassed General Hospital, Middle East Institute of Health, Beirut, Lebanon
16. Department of Pediatrics, Queen Rani Childrenâ€™s Hospital, Amman, Jordan
17. The Royal Hospital, Muscat, Oman
18. King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia
19. Ibn Rochd University Hospital, University of Hassan II, Casablanca, Morocco
20. King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
21. u University Hospital Basel, Basel, Switzerland
22. v Aichi Medical University Hospital, Nagakute, Japan
23. University, Leipzig, Germany

Source: Hematology/ Oncology and Stem Cell Therapy Published:2023

Abstract

The World Health Organization-designated Eastern Mediterranean region (EMRO) consists of 22 countries in North Africa and Western Asia with a collective population of over 679 million. The area comprises some of the wealthiest countries per capita income and some of the poorest. The population structure is also unique and contrasts with western countries, with a much younger population. The region sits in the heart of the thalassemia belt. Many countries have a significant prevalence of sickle cell disease, and cancer is on the rise in the region. Therefore, the strategic priorities for the growth and development of hematopoietic stem cell transplantation (HSCT) differ from country to country based on resources, healthcare challenges, and prevalent infrastructure. Thirty-one reporting teams to the Eastern Mediterranean Blood and Marrow Transplantation Group have active HSCT programs in 12 countries; allogeneic transplants outnumber autologous transplants, and the proportion of allotransplants for non-malignant conditions is higher in the EMRO region than in Western Europe and North America. The vast majority (99%) of allotransplants are from matched related donors. Matched unrelated donors and other alternate donor transplants are underutilized. The chance of finding a matched related donor for allografts is higher, with a significant chance of finding matched donors among non-sibling related donors. Reasons for relatively lower rates of transplants compared with other countries are multifactorial. Capacity building, development of newer centers, innovative funding, and better utilization of information technology are required to make transplantation as an accessible modality to more patients. Cost-effectiveness and cost-containment, regulation, and ensuring quality will all be priorities in planning HSCT development in the region. © 2023 King Faisal Specialist Hospital and Research Centre. All rights reserved.

Related Docs

View other Related Docs

1. Narrowing the Gap for Hematopoietic Stem Cell Transplantation in the East-Mediterranean/African Region: Comparison With Global Hsct Indications and Trends, Bone Marrow Transplantation (2019)

2. First Report of Pediatric Hematopoietic Stem Cell Transplantation Activities in the Eastern Mediterranean Region From 1984 to 2011: On Behalf of the Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation Group, Bone Marrow Transplantation (2017)

3. One and a Half Million Hematopoietic Stem Cell Transplants: Continuous and Differential Improvement in Worldwide Access With the Use of Non-Identical Family Donors, Haematologica (2022)

4. Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region (Emro) 2011-2012: A Comprehensive Report on Behalf of the Eastern Mediterranean Blood and Marrow Transplantation Group (Embmt), Hematology/ Oncology and Stem Cell Therapy (2015)

5. Hematopoietic Sct in Iranian Children 1991-2012, Bone Marrow Transplantation (2015)

6. Advances in Hematopoietic Stem Cell Transplantation in the Asia-Pacific Region: The Second Report From Apbmt 2005–2015, Bone Marrow Transplantation (2019)

7. Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean, Hematology/ Oncology and Stem Cell Therapy (2020)

8. Cost and Quality Issues in Establishing Hematopoietic Cell Transplant Program in Developing Countries, Hematology/ Oncology and Stem Cell Therapy (2017)

Experts (# of related papers)

View all Related Experts

Amir Ali Hamidieh (8)

Maryam Behfar (2)

Style	Citing Format
MLA	Ahmed SO, et al.. "Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region." Hematology/ Oncology and Stem Cell Therapy, vol. 16, no. 3, 2023, pp. 162-169.
APA	Ahmed SO, Fakih RE, Elhaddad A, Hamidieh AA, Altbakhi A, Chaudhry QUN, Bazarbachi A, Adil S, Alkhabori M, Othman TB, Gaziev J, Khalaf M, Alshammeri S, Alotaibi S, Alshahrani M, Bekadja MA, Ibrahim A, Alwahadneh AM, Altarshi M, ... Aljurf M (2023). Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region. Hematology/ Oncology and Stem Cell Therapy, 16(3), 162-169.
Chicago	Ahmed SO, Fakih RE, Elhaddad A, Hamidieh AA, Altbakhi A, Chaudhry QUN, Bazarbachi A, et al.. "Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region." Hematology/ Oncology and Stem Cell Therapy 16, no. 3 (2023): 162-169.
Harvard	Ahmed SO et al. (2023) 'Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region', Hematology/ Oncology and Stem Cell Therapy, 16(3), pp. 162-169.
Vancouver	Ahmed SO, Fakih RE, Elhaddad A, Hamidieh AA, Altbakhi A, Chaudhry QUN, et al.. Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region. Hematology/ Oncology and Stem Cell Therapy. 2023;16(3):162-169.
BibTex	@article{ author = {Ahmed SO and Fakih RE and Elhaddad A and Hamidieh AA and Altbakhi A and Chaudhry QUN and Bazarbachi A and Adil S and Alkhabori M and Othman TB and Gaziev J and Khalaf M and Alshammeri S and Alotaibi S and Alshahrani M and Bekadja MA and Ibrahim A and Alwahadneh AM and Altarshi M and Alsaeed A and Madani A and Abboud M and Abujazar H and Bakr M and Abosoudah I and Cheikh JE and Almasari A and Alfraih F and Baldomero H and Elsolh H and Niederwieser D and Chaudhri N and Aljurf M}, title = {Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region}, journal = {Hematology/ Oncology and Stem Cell Therapy}, volume = {16}, number = {3}, pages = {162-169}, year = {2023} }
RIS	TY - JOUR AU - Ahmed SO AU - Fakih RE AU - Elhaddad A AU - Hamidieh AA AU - Altbakhi A AU - Chaudhry QUN AU - Bazarbachi A AU - Adil S AU - Alkhabori M AU - Othman TB AU - Gaziev J AU - Khalaf M AU - Alshammeri S AU - Alotaibi S AU - Alshahrani M AU - Bekadja MA AU - Ibrahim A AU - Alwahadneh AM AU - Altarshi M AU - Alsaeed A AU - Madani A AU - Abboud M AU - Abujazar H AU - Bakr M AU - Abosoudah I AU - Cheikh JE AU - Almasari A AU - Alfraih F AU - Baldomero H AU - Elsolh H AU - Niederwieser D AU - Chaudhri N AU - Aljurf M TI - Strategic Priorities for Hematopoietic Stem Cell Transplantation in the Emro Region JO - Hematology/ Oncology and Stem Cell Therapy VL - 16 IS - 3 SP - 162 EP - 169 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract